Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Minimally Invasive Surgical Procedures | 96 | 2023 | 306 | 17.500 |
Why?
|
Spinal Fusion | 70 | 2023 | 562 | 10.720 |
Why?
|
Lumbar Vertebrae | 59 | 2023 | 523 | 9.050 |
Why?
|
Diskectomy | 29 | 2022 | 219 | 6.100 |
Why?
|
Thoracic Vertebrae | 27 | 2018 | 115 | 5.860 |
Why?
|
Neurosurgical Procedures | 26 | 2021 | 162 | 5.480 |
Why?
|
Decompression, Surgical | 23 | 2017 | 151 | 5.370 |
Why?
|
Intervertebral Disc Displacement | 25 | 2022 | 131 | 5.120 |
Why?
|
Spine | 23 | 2021 | 132 | 5.090 |
Why?
|
Scoliosis | 15 | 2023 | 36 | 4.520 |
Why?
|
Postoperative Complications | 46 | 2023 | 997 | 4.160 |
Why?
|
Spinal Cord Injuries | 9 | 2023 | 48 | 3.920 |
Why?
|
Cervical Vertebrae | 20 | 2022 | 382 | 3.700 |
Why?
|
Spinal Diseases | 18 | 2021 | 155 | 3.540 |
Why?
|
Lordosis | 14 | 2022 | 45 | 3.180 |
Why?
|
Treatment Outcome | 76 | 2023 | 3809 | 3.180 |
Why?
|
Endoscopy | 16 | 2012 | 199 | 3.100 |
Why?
|
Spinal Stenosis | 9 | 2015 | 57 | 2.940 |
Why?
|
Humans | 187 | 2023 | 31070 | 2.880 |
Why?
|
Spondylolisthesis | 12 | 2023 | 53 | 2.800 |
Why?
|
Middle Aged | 108 | 2023 | 10239 | 2.710 |
Why?
|
Intervertebral Disc Degeneration | 7 | 2022 | 130 | 2.610 |
Why?
|
Microsurgery | 13 | 2022 | 45 | 2.460 |
Why?
|
Female | 112 | 2023 | 17018 | 2.350 |
Why?
|
Radiculopathy | 7 | 2022 | 65 | 2.350 |
Why?
|
Spinal Cord Compression | 10 | 2016 | 31 | 2.280 |
Why?
|
Male | 106 | 2023 | 16499 | 2.220 |
Why?
|
Spinal Cord Neoplasms | 8 | 2015 | 35 | 2.210 |
Why?
|
Spondylosis | 7 | 2019 | 32 | 2.150 |
Why?
|
Laminectomy | 10 | 2014 | 65 | 2.070 |
Why?
|
Retrospective Studies | 51 | 2023 | 3665 | 1.990 |
Why?
|
Aged | 78 | 2023 | 10079 | 1.950 |
Why?
|
Spinal Curvatures | 9 | 2020 | 13 | 1.880 |
Why?
|
Adult | 78 | 2023 | 8949 | 1.850 |
Why?
|
Bone Screws | 13 | 2017 | 180 | 1.740 |
Why?
|
Orthopedic Procedures | 7 | 2018 | 329 | 1.710 |
Why?
|
Spinal Cord | 8 | 2023 | 107 | 1.700 |
Why?
|
Patient Reported Outcome Measures | 4 | 2021 | 434 | 1.680 |
Why?
|
Foraminotomy | 4 | 2019 | 8 | 1.640 |
Why?
|
Pedicle Screws | 3 | 2015 | 19 | 1.450 |
Why?
|
Fluoroscopy | 6 | 2016 | 63 | 1.290 |
Why?
|
Length of Stay | 13 | 2021 | 339 | 1.250 |
Why?
|
Low Back Pain | 6 | 2015 | 144 | 1.240 |
Why?
|
Quality of Life | 8 | 2021 | 696 | 1.160 |
Why?
|
Prostheses and Implants | 5 | 2009 | 170 | 1.090 |
Why?
|
Spinal Neoplasms | 7 | 2013 | 41 | 1.060 |
Why?
|
Sacrum | 5 | 2018 | 29 | 1.050 |
Why?
|
Embolization, Therapeutic | 3 | 2022 | 41 | 1.050 |
Why?
|
Patient Satisfaction | 2 | 2021 | 310 | 1.040 |
Why?
|
Follow-Up Studies | 27 | 2021 | 1935 | 1.030 |
Why?
|
Intervertebral Disc | 5 | 2010 | 218 | 0.980 |
Why?
|
Spinal Fractures | 7 | 2009 | 63 | 0.980 |
Why?
|
Back Pain | 11 | 2023 | 71 | 0.970 |
Why?
|
Mental Health | 3 | 2021 | 113 | 0.960 |
Why?
|
Spinal Cord Diseases | 5 | 2013 | 53 | 0.930 |
Why?
|
Diskectomy, Percutaneous | 3 | 2010 | 6 | 0.910 |
Why?
|
Pain Measurement | 13 | 2021 | 489 | 0.870 |
Why?
|
Intraoperative Complications | 3 | 2015 | 75 | 0.860 |
Why?
|
Bone Transplantation | 5 | 2015 | 234 | 0.860 |
Why?
|
Drainage | 1 | 2023 | 52 | 0.860 |
Why?
|
Intraoperative Neurophysiological Monitoring | 2 | 2021 | 13 | 0.860 |
Why?
|
Dura Mater | 3 | 2020 | 22 | 0.850 |
Why?
|
Oligodendrocyte Precursor Cells | 1 | 2022 | 1 | 0.830 |
Why?
|
Cervical Cord | 1 | 2022 | 2 | 0.830 |
Why?
|
Neck Injuries | 1 | 2022 | 3 | 0.830 |
Why?
|
Dysbiosis | 1 | 2023 | 72 | 0.830 |
Why?
|
Magnetic Resonance Imaging | 17 | 2017 | 1314 | 0.750 |
Why?
|
Atlanto-Occipital Joint | 3 | 2015 | 18 | 0.730 |
Why?
|
Spinal Osteophytosis | 3 | 2007 | 14 | 0.720 |
Why?
|
Radiography | 21 | 2017 | 695 | 0.700 |
Why?
|
Cellular Reprogramming | 1 | 2020 | 5 | 0.700 |
Why?
|
Pluripotent Stem Cells | 1 | 2020 | 6 | 0.700 |
Why?
|
Motivation | 1 | 2020 | 103 | 0.690 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 20 | 0.680 |
Why?
|
Kyphosis | 5 | 2020 | 28 | 0.660 |
Why?
|
Cohort Studies | 10 | 2021 | 2045 | 0.660 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 119 | 0.650 |
Why?
|
Disability Evaluation | 12 | 2018 | 333 | 0.640 |
Why?
|
Reoperation | 15 | 2020 | 952 | 0.640 |
Why?
|
Prospective Studies | 13 | 2021 | 1898 | 0.620 |
Why?
|
Aged, 80 and over | 22 | 2021 | 5192 | 0.620 |
Why?
|
Blood Loss, Surgical | 7 | 2015 | 67 | 0.610 |
Why?
|
Ependymoma | 2 | 2009 | 14 | 0.610 |
Why?
|
Osteotomy | 3 | 2019 | 171 | 0.600 |
Why?
|
Patient Readmission | 2 | 2017 | 132 | 0.600 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2017 | 2 | 0.580 |
Why?
|
Muscular Diseases | 1 | 2017 | 17 | 0.570 |
Why?
|
Video Recording | 2 | 2013 | 44 | 0.560 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 4 | 0.560 |
Why?
|
Wounds, Gunshot | 1 | 2016 | 4 | 0.550 |
Why?
|
Brown-Sequard Syndrome | 1 | 2016 | 4 | 0.550 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2016 | 4 | 0.550 |
Why?
|
Young Adult | 11 | 2018 | 2063 | 0.540 |
Why?
|
Age of Onset | 1 | 2016 | 111 | 0.540 |
Why?
|
Foreign-Body Migration | 2 | 2015 | 23 | 0.540 |
Why?
|
Health Care Costs | 2 | 2016 | 72 | 0.520 |
Why?
|
Atlanto-Axial Joint | 2 | 2015 | 18 | 0.520 |
Why?
|
Spondylolysis | 1 | 2015 | 3 | 0.520 |
Why?
|
Propensity Score | 3 | 2023 | 36 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 10 | 2016 | 818 | 0.500 |
Why?
|
Athletes | 1 | 2015 | 78 | 0.490 |
Why?
|
Postoperative Care | 6 | 2021 | 132 | 0.490 |
Why?
|
Thoracoscopy | 3 | 2014 | 20 | 0.480 |
Why?
|
Neurosurgery | 3 | 2015 | 49 | 0.480 |
Why?
|
Hypothermia, Induced | 1 | 2014 | 22 | 0.470 |
Why?
|
Quality of Health Care | 1 | 2015 | 146 | 0.460 |
Why?
|
Neuroendoscopy | 2 | 2013 | 8 | 0.460 |
Why?
|
Hernia | 1 | 2014 | 8 | 0.460 |
Why?
|
Herniorrhaphy | 1 | 2014 | 31 | 0.450 |
Why?
|
Adolescent | 12 | 2023 | 2403 | 0.450 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 14 | 0.450 |
Why?
|
Osteoporosis | 2 | 2006 | 85 | 0.440 |
Why?
|
Functional Laterality | 1 | 2013 | 88 | 0.430 |
Why?
|
Vertebroplasty | 2 | 2009 | 10 | 0.420 |
Why?
|
Spinal Nerve Roots | 4 | 2003 | 29 | 0.420 |
Why?
|
Nerve Compression Syndromes | 4 | 2003 | 27 | 0.420 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 4 | 0.410 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 230 | 0.400 |
Why?
|
Databases, Factual | 8 | 2018 | 354 | 0.400 |
Why?
|
Syringomyelia | 3 | 2007 | 12 | 0.400 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 54 | 0.390 |
Why?
|
Parkinson Disease | 1 | 2020 | 1069 | 0.390 |
Why?
|
Obesity | 2 | 2015 | 307 | 0.360 |
Why?
|
Posture | 4 | 2018 | 72 | 0.340 |
Why?
|
Costs and Cost Analysis | 3 | 2019 | 37 | 0.340 |
Why?
|
Zygapophyseal Joint | 3 | 2006 | 46 | 0.340 |
Why?
|
Intracranial Aneurysm | 1 | 2009 | 34 | 0.330 |
Why?
|
Carcinoma in Situ | 1 | 2009 | 9 | 0.330 |
Why?
|
Stents | 1 | 2009 | 85 | 0.320 |
Why?
|
Checklist | 2 | 2023 | 38 | 0.310 |
Why?
|
Surgical Wound Infection | 1 | 2009 | 103 | 0.310 |
Why?
|
Cadaver | 5 | 2009 | 380 | 0.310 |
Why?
|
Evoked Potentials, Motor | 3 | 2021 | 13 | 0.300 |
Why?
|
Subarachnoid Space | 1 | 2007 | 8 | 0.300 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2007 | 7 | 0.300 |
Why?
|
Congenital Abnormalities | 2 | 2017 | 9 | 0.300 |
Why?
|
Age Factors | 4 | 2018 | 874 | 0.300 |
Why?
|
Pseudarthrosis | 3 | 2011 | 13 | 0.290 |
Why?
|
Recurrence | 5 | 2012 | 375 | 0.280 |
Why?
|
Rhizotomy | 1 | 2006 | 2 | 0.280 |
Why?
|
Models, Biological | 1 | 2009 | 346 | 0.280 |
Why?
|
Cysts | 1 | 2006 | 16 | 0.270 |
Why?
|
Range of Motion, Articular | 4 | 2015 | 736 | 0.270 |
Why?
|
Intermittent Claudication | 1 | 2006 | 4 | 0.270 |
Why?
|
Biomechanical Phenomena | 4 | 2015 | 699 | 0.260 |
Why?
|
Evoked Potentials, Somatosensory | 3 | 2021 | 10 | 0.260 |
Why?
|
Arthroplasty | 2 | 2022 | 141 | 0.260 |
Why?
|
Paralysis | 2 | 2023 | 20 | 0.260 |
Why?
|
Incidence | 4 | 2015 | 790 | 0.260 |
Why?
|
Lumbosacral Region | 5 | 2017 | 80 | 0.250 |
Why?
|
Feasibility Studies | 6 | 2009 | 244 | 0.250 |
Why?
|
Nervous System Diseases | 3 | 2012 | 156 | 0.250 |
Why?
|
Electric Stimulation Therapy | 2 | 2003 | 46 | 0.240 |
Why?
|
Movement | 1 | 2005 | 137 | 0.240 |
Why?
|
Pelvis | 3 | 2018 | 33 | 0.230 |
Why?
|
Tuberculosis, Spinal | 1 | 2003 | 2 | 0.220 |
Why?
|
Decompression | 1 | 2023 | 23 | 0.220 |
Why?
|
Cell Differentiation | 2 | 2020 | 152 | 0.220 |
Why?
|
Intervertebral Disc Chemolysis | 1 | 2003 | 5 | 0.220 |
Why?
|
Frailty | 1 | 2023 | 39 | 0.210 |
Why?
|
Electromyography | 2 | 2021 | 78 | 0.210 |
Why?
|
Central Nervous System | 1 | 2023 | 56 | 0.210 |
Why?
|
Time Factors | 5 | 2013 | 1681 | 0.210 |
Why?
|
Tacrolimus | 1 | 2022 | 16 | 0.210 |
Why?
|
Recovery of Function | 3 | 2015 | 298 | 0.210 |
Why?
|
Varicose Veins | 1 | 2022 | 3 | 0.210 |
Why?
|
Hypesthesia | 1 | 2022 | 8 | 0.210 |
Why?
|
Surgery, Computer-Assisted | 2 | 2016 | 62 | 0.210 |
Why?
|
Benzophenones | 1 | 2021 | 27 | 0.190 |
Why?
|
Polymers | 1 | 2021 | 42 | 0.190 |
Why?
|
Decision Making | 2 | 2014 | 237 | 0.190 |
Why?
|
Internal Fixators | 3 | 2004 | 53 | 0.190 |
Why?
|
Fracture Fixation, Internal | 2 | 1999 | 75 | 0.190 |
Why?
|
Convalescence | 1 | 2020 | 7 | 0.190 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 370 | 0.190 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 59 | 0.180 |
Why?
|
Pain | 2 | 2020 | 426 | 0.180 |
Why?
|
Leg | 1 | 2020 | 51 | 0.180 |
Why?
|
Postoperative Period | 3 | 2017 | 303 | 0.180 |
Why?
|
Genomic Instability | 1 | 2020 | 8 | 0.180 |
Why?
|
Regenerative Medicine | 1 | 2020 | 5 | 0.180 |
Why?
|
Minimal Clinically Important Difference | 1 | 2021 | 130 | 0.170 |
Why?
|
Cervical Atlas | 1 | 1999 | 4 | 0.170 |
Why?
|
Allografts | 1 | 2021 | 202 | 0.170 |
Why?
|
Axis, Cervical Vertebra | 1 | 1999 | 9 | 0.170 |
Why?
|
Models, Anatomic | 2 | 2010 | 54 | 0.170 |
Why?
|
Pain, Postoperative | 2 | 2013 | 334 | 0.170 |
Why?
|
Algorithms | 3 | 2019 | 416 | 0.170 |
Why?
|
Biocompatible Materials | 1 | 2020 | 104 | 0.170 |
Why?
|
Neck | 1 | 2019 | 35 | 0.160 |
Why?
|
Bone Plates | 1 | 2019 | 64 | 0.160 |
Why?
|
Joint Instability | 4 | 2000 | 405 | 0.160 |
Why?
|
Finite Element Analysis | 2 | 2009 | 50 | 0.160 |
Why?
|
Rehabilitation Centers | 1 | 2018 | 4 | 0.160 |
Why?
|
Home Care Services | 1 | 2018 | 21 | 0.160 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 226 | 0.150 |
Why?
|
Operative Time | 2 | 2016 | 85 | 0.150 |
Why?
|
Diagnosis-Related Groups | 1 | 2017 | 10 | 0.150 |
Why?
|
Patient Selection | 1 | 2019 | 246 | 0.150 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 149 | 0.150 |
Why?
|
Arthroscopy | 1 | 2005 | 892 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2017 | 65 | 0.150 |
Why?
|
Muscle Denervation | 1 | 2017 | 3 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 32 | 0.140 |
Why?
|
Activities of Daily Living | 1 | 2020 | 551 | 0.140 |
Why?
|
Single-Blind Method | 1 | 2017 | 120 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 1 | 2016 | 5 | 0.140 |
Why?
|
Medicare | 1 | 2017 | 127 | 0.140 |
Why?
|
Anemia | 1 | 2017 | 100 | 0.140 |
Why?
|
Intensive Care Units | 1 | 2019 | 328 | 0.130 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2015 | 1 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 225 | 0.130 |
Why?
|
Nerve Degeneration | 1 | 1996 | 54 | 0.130 |
Why?
|
Fetal Tissue Transplantation | 3 | 2001 | 25 | 0.130 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 42 | 0.120 |
Why?
|
Defensive Medicine | 1 | 2015 | 1 | 0.120 |
Why?
|
Risk Factors | 4 | 2016 | 2593 | 0.120 |
Why?
|
Health Surveys | 1 | 2015 | 99 | 0.120 |
Why?
|
Narcotics | 3 | 2005 | 37 | 0.120 |
Why?
|
Brain Diseases | 2 | 2000 | 82 | 0.120 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2013 | 26 | 0.110 |
Why?
|
Subdural Effusion | 2 | 2003 | 7 | 0.110 |
Why?
|
Astrocytoma | 1 | 2013 | 25 | 0.110 |
Why?
|
Lumbosacral Plexus | 1 | 2013 | 5 | 0.110 |
Why?
|
Central Cord Syndrome | 1 | 2013 | 1 | 0.110 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 1993 | 2 | 0.110 |
Why?
|
Body Mass Index | 1 | 2015 | 453 | 0.110 |
Why?
|
Intraoperative Care | 2 | 2012 | 46 | 0.110 |
Why?
|
Methylprednisolone | 1 | 1993 | 24 | 0.110 |
Why?
|
Odontoid Process | 1 | 1992 | 10 | 0.110 |
Why?
|
Tarlov Cysts | 1 | 2012 | 1 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2013 | 344 | 0.100 |
Why?
|
Bupivacaine | 1 | 1993 | 57 | 0.100 |
Why?
|
Glioblastoma | 1 | 2012 | 14 | 0.100 |
Why?
|
Logistic Models | 1 | 2013 | 410 | 0.100 |
Why?
|
Prone Position | 1 | 2012 | 33 | 0.100 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 39 | 0.100 |
Why?
|
Chondrocytes | 3 | 2006 | 208 | 0.100 |
Why?
|
Calcinosis | 1 | 2012 | 50 | 0.100 |
Why?
|
Lipomatosis | 1 | 1992 | 4 | 0.100 |
Why?
|
Self Report | 1 | 2013 | 231 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 1993 | 103 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 216 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2012 | 71 | 0.100 |
Why?
|
Abdominal Injuries | 1 | 2011 | 4 | 0.100 |
Why?
|
Psoas Muscles | 1 | 2011 | 6 | 0.100 |
Why?
|
Prednisone | 1 | 1992 | 69 | 0.100 |
Why?
|
Polyradiculopathy | 1 | 2011 | 2 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2012 | 133 | 0.100 |
Why?
|
Computer Simulation | 2 | 2010 | 222 | 0.090 |
Why?
|
Neurologic Examination | 3 | 1998 | 138 | 0.090 |
Why?
|
Visual Analog Scale | 3 | 2017 | 60 | 0.090 |
Why?
|
Case-Control Studies | 2 | 2018 | 663 | 0.090 |
Why?
|
Transplantation, Homologous | 2 | 2003 | 296 | 0.090 |
Why?
|
Endoscopes | 2 | 2007 | 10 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2013 | 375 | 0.090 |
Why?
|
Polymethacrylic Acids | 1 | 2009 | 5 | 0.080 |
Why?
|
Ribs | 1 | 2009 | 18 | 0.080 |
Why?
|
Fractures, Compression | 1 | 2009 | 8 | 0.080 |
Why?
|
Cerebral Angiography | 1 | 2009 | 33 | 0.080 |
Why?
|
Mycetoma | 1 | 1989 | 1 | 0.080 |
Why?
|
Cranial Sinuses | 1 | 1989 | 5 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 331 | 0.080 |
Why?
|
Elastic Modulus | 1 | 2009 | 12 | 0.080 |
Why?
|
Motion | 1 | 2009 | 23 | 0.080 |
Why?
|
Compressive Strength | 1 | 2009 | 29 | 0.080 |
Why?
|
Stress, Mechanical | 1 | 2009 | 173 | 0.080 |
Why?
|
Weight-Bearing | 1 | 2009 | 170 | 0.080 |
Why?
|
Ultrasonography | 2 | 2007 | 271 | 0.080 |
Why?
|
Epidural Space | 2 | 2022 | 26 | 0.080 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2008 | 18 | 0.080 |
Why?
|
Meningioma | 2 | 2000 | 20 | 0.070 |
Why?
|
Sensation Disorders | 2 | 1999 | 13 | 0.070 |
Why?
|
Neural Tube Defects | 1 | 2007 | 9 | 0.070 |
Why?
|
Health Status | 1 | 2008 | 239 | 0.070 |
Why?
|
Aging | 2 | 2011 | 1727 | 0.070 |
Why?
|
Microscopy | 1 | 2007 | 10 | 0.070 |
Why?
|
Prognosis | 3 | 2016 | 924 | 0.070 |
Why?
|
Dissection | 1 | 2007 | 27 | 0.070 |
Why?
|
Laser Therapy | 1 | 2006 | 13 | 0.070 |
Why?
|
Spinal Canal | 1 | 2006 | 15 | 0.070 |
Why?
|
Equipment Design | 1 | 2007 | 188 | 0.070 |
Why?
|
Animals | 4 | 2003 | 4724 | 0.060 |
Why?
|
Synovial Cyst | 1 | 2004 | 4 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2018 | 818 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2003 | 30 | 0.060 |
Why?
|
History, 18th Century | 1 | 2003 | 8 | 0.050 |
Why?
|
History, Ancient | 1 | 2003 | 7 | 0.050 |
Why?
|
Chemotaxis | 1 | 2003 | 6 | 0.050 |
Why?
|
Tissue Preservation | 1 | 2003 | 6 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2003 | 16 | 0.050 |
Why?
|
Mesoderm | 1 | 2003 | 19 | 0.050 |
Why?
|
Osteoclasts | 1 | 2003 | 22 | 0.050 |
Why?
|
Cell Division | 1 | 2003 | 113 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2003 | 55 | 0.050 |
Why?
|
History, 20th Century | 1 | 2003 | 70 | 0.050 |
Why?
|
Mouth | 1 | 2002 | 12 | 0.050 |
Why?
|
Polymethyl Methacrylate | 1 | 2002 | 16 | 0.050 |
Why?
|
Bone Matrix | 1 | 2003 | 28 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 387 | 0.050 |
Why?
|
Osteoblasts | 1 | 2003 | 63 | 0.050 |
Why?
|
Pharynx | 1 | 2002 | 15 | 0.050 |
Why?
|
Models, Animal | 1 | 2003 | 130 | 0.050 |
Why?
|
Bone Remodeling | 1 | 2003 | 46 | 0.050 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 198 | 0.050 |
Why?
|
Neck Pain | 1 | 2002 | 34 | 0.050 |
Why?
|
Consensus | 1 | 2023 | 112 | 0.050 |
Why?
|
Bone Regeneration | 1 | 2003 | 76 | 0.050 |
Why?
|
Osteogenesis | 1 | 2003 | 107 | 0.050 |
Why?
|
Rabbits | 1 | 2003 | 286 | 0.050 |
Why?
|
Pregnancy | 1 | 2003 | 405 | 0.050 |
Why?
|
Bone Cements | 1 | 2002 | 95 | 0.050 |
Why?
|
Survival Rate | 2 | 2013 | 407 | 0.050 |
Why?
|
Bacterial Infections | 2 | 2004 | 72 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 76 | 0.050 |
Why?
|
Molecular Biology | 1 | 2000 | 14 | 0.050 |
Why?
|
Growth Substances | 1 | 2000 | 39 | 0.050 |
Why?
|
Granuloma | 1 | 2000 | 15 | 0.050 |
Why?
|
Collagen | 1 | 2000 | 103 | 0.040 |
Why?
|
Surveys and Questionnaires | 2 | 2015 | 1209 | 0.040 |
Why?
|
Meningeal Neoplasms | 1 | 2000 | 16 | 0.040 |
Why?
|
United States | 2 | 2017 | 2375 | 0.040 |
Why?
|
Cell Survival | 1 | 2000 | 164 | 0.040 |
Why?
|
Sarcoidosis | 1 | 2000 | 14 | 0.040 |
Why?
|
Cell Movement | 1 | 2000 | 105 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2000 | 82 | 0.040 |
Why?
|
Immobilization | 1 | 1999 | 15 | 0.040 |
Why?
|
Orthopedic Fixation Devices | 2 | 1997 | 25 | 0.040 |
Why?
|
Proteoglycans | 1 | 2000 | 345 | 0.040 |
Why?
|
Thoracotomy | 1 | 1998 | 26 | 0.040 |
Why?
|
Observer Variation | 1 | 2018 | 118 | 0.040 |
Why?
|
Survival Analysis | 1 | 1998 | 322 | 0.040 |
Why?
|
Surgeons | 1 | 2018 | 87 | 0.040 |
Why?
|
Wound Healing | 1 | 1997 | 174 | 0.030 |
Why?
|
Inpatients | 1 | 2017 | 150 | 0.030 |
Why?
|
Osteomyelitis | 2 | 1992 | 23 | 0.030 |
Why?
|
Malpractice | 1 | 2015 | 10 | 0.030 |
Why?
|
Longitudinal Ligaments | 1 | 1994 | 2 | 0.030 |
Why?
|
Fascia | 1 | 1994 | 9 | 0.030 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1994 | 6 | 0.030 |
Why?
|
Prevalence | 1 | 2016 | 500 | 0.030 |
Why?
|
Pleural Effusion | 1 | 1994 | 12 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1994 | 27 | 0.030 |
Why?
|
Dogs | 2 | 1993 | 264 | 0.030 |
Why?
|
Neurilemmoma | 1 | 1994 | 17 | 0.030 |
Why?
|
Risk | 1 | 2015 | 223 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2015 | 62 | 0.030 |
Why?
|
SEER Program | 1 | 2013 | 41 | 0.030 |
Why?
|
Contraindications | 1 | 1993 | 42 | 0.030 |
Why?
|
Hospitalization | 1 | 2016 | 336 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2015 | 159 | 0.030 |
Why?
|
Intraoperative Period | 1 | 1993 | 34 | 0.030 |
Why?
|
ROC Curve | 1 | 2013 | 145 | 0.030 |
Why?
|
Child | 1 | 1997 | 1431 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2012 | 18 | 0.030 |
Why?
|
Spinal Injuries | 1 | 1993 | 28 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 1993 | 246 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2013 | 404 | 0.030 |
Why?
|
Myelography | 1 | 1992 | 10 | 0.030 |
Why?
|
Disease Management | 1 | 2013 | 126 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2016 | 1133 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 1993 | 90 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 1993 | 108 | 0.030 |
Why?
|
Surgical Flaps | 1 | 1992 | 54 | 0.020 |
Why?
|
Pleura | 1 | 1991 | 10 | 0.020 |
Why?
|
Contrast Media | 1 | 2012 | 136 | 0.020 |
Why?
|
Morbidity | 1 | 2011 | 65 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 1991 | 28 | 0.020 |
Why?
|
Fractures, Bone | 1 | 1992 | 81 | 0.020 |
Why?
|
Debridement | 2 | 2004 | 105 | 0.020 |
Why?
|
Orthopedics | 1 | 1993 | 128 | 0.020 |
Why?
|
Scapula | 1 | 1991 | 84 | 0.020 |
Why?
|
Muscular Atrophy | 1 | 2010 | 6 | 0.020 |
Why?
|
Arthrodesis | 1 | 2010 | 45 | 0.020 |
Why?
|
Pseudallescheria | 1 | 1989 | 1 | 0.020 |
Why?
|
Movement Disorders | 1 | 2010 | 118 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2009 | 28 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1992 | 365 | 0.020 |
Why?
|
Spondylitis, Ankylosing | 1 | 2008 | 46 | 0.020 |
Why?
|
Risk Assessment | 1 | 2009 | 718 | 0.020 |
Why?
|
Crystallization | 1 | 2006 | 5 | 0.020 |
Why?
|
Chondrocalcinosis | 1 | 2006 | 5 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 23 | 0.020 |
Why?
|
Age Distribution | 1 | 2006 | 96 | 0.020 |
Why?
|
Preoperative Care | 1 | 2006 | 144 | 0.020 |
Why?
|
Synovial Membrane | 1 | 2006 | 84 | 0.020 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2004 | 3 | 0.020 |
Why?
|
Periaqueductal Gray | 1 | 1984 | 2 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 1984 | 24 | 0.010 |
Why?
|
H-Reflex | 1 | 2001 | 1 | 0.010 |
Why?
|
Median Nerve | 1 | 2001 | 1 | 0.010 |
Why?
|
Tibial Nerve | 1 | 2001 | 7 | 0.010 |
Why?
|
Neural Conduction | 1 | 2001 | 8 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 32 | 0.010 |
Why?
|
Action Potentials | 1 | 2001 | 144 | 0.010 |
Why?
|
Pilot Projects | 1 | 2001 | 429 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 408 | 0.010 |
Why?
|
Work | 1 | 1996 | 10 | 0.010 |
Why?
|
Extremities | 1 | 1996 | 33 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 1996 | 100 | 0.010 |
Why?
|
Analgesics | 1 | 1996 | 109 | 0.010 |
Why?
|
Chronic Disease | 1 | 1996 | 534 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1997 | 420 | 0.010 |
Why?
|
Equipment Failure | 1 | 1992 | 53 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 1984 | 48 | 0.000 |
Why?
|